92 related articles for article (PubMed ID: 3145826)
21. Evaluation of the effects of thyrotropin releasing hormone (TRH) therapy on regional cerebral blood flow in the cerebellar variant of multiple system atrophy using 3DSRT.
Kimura N; Kumamoto T; Masuda T; Nomura Y; Hanaoka T; Hazama Y; Okazaki T
J Neuroimaging; 2011 Apr; 21(2):132-7. PubMed ID: 19674246
[TBL] [Abstract][Full Text] [Related]
22. Effect of thyrotropin-releasing hormone on cerebral blood flow in conscious rat.
Kondoh Y; Mizusawa S; Murakami M; Nagata K; Sasaki H; Nakamichi H; Watanabe K; Uemura K
J Cereb Blood Flow Metab; 1989 Apr; 9(2):196-203. PubMed ID: 2493461
[TBL] [Abstract][Full Text] [Related]
23. Branched-chain amino acid therapy for spinocerebellar degeneration: a pilot clinical crossover trial.
Mori N; Adachi Y; Takeshima T; Kashiwaya Y; Okada A; Nakashima K
Intern Med; 1999 May; 38(5):401-6. PubMed ID: 10397076
[TBL] [Abstract][Full Text] [Related]
24. Cerebral uptake of 99mTc-bicisate in patients with cerebrovascular disease in comparison with CBF and CMRO2 measured by positron emission tomography.
Shishido F; Uemura K; Murakami M; Inugami A; Ogawa T; Fujita H; Shimosegawa E; Kanno I; Aizawa Y; Nagata K
J Cereb Blood Flow Metab; 1994 Jan; 14 Suppl 1():S66-75. PubMed ID: 8263074
[TBL] [Abstract][Full Text] [Related]
25. Oral thyrotropin-releasing hormone treatment in inherited ataxias.
Bonuccelli U; Nuti A; Cei G; Rossi G; Grasso L; Martino E; Muratorio A
Clin Neuropharmacol; 1988 Dec; 11(6):520-8. PubMed ID: 3148366
[TBL] [Abstract][Full Text] [Related]
26. [Spinocerebellar degeneration].
Takayanagi T
Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):377-80. PubMed ID: 8315331
[No Abstract] [Full Text] [Related]
27. [Spinocerebellar degeneration].
Sugai Y
Ryoikibetsu Shokogun Shirizu; 2003; (40):272-4. PubMed ID: 14626118
[No Abstract] [Full Text] [Related]
28. [Relationship between cognitive function and regional CBF in hereditary spinocerebellar degeneration--comparison between Joseph disease and OPCA of Menzel type].
Koshi Y; Kitamura S; Terashi A
Rinsho Shinkeigaku; 1995 Mar; 35(3):237-42. PubMed ID: 7614743
[TBL] [Abstract][Full Text] [Related]
29. Hemodynamic and metabolic effects of cerebral revascularization.
Leblanc R; Tyler JL; Mohr G; Meyer E; Diksic M; Yamamoto L; Taylor L; Gauthier S; Hakim A
J Neurosurg; 1987 Apr; 66(4):529-35. PubMed ID: 3494109
[TBL] [Abstract][Full Text] [Related]
30. [Studies on the hypothalamic-pituitary dopaminergic system in Parkinson's disease and spinocerebellar degeneration. Response to TRH and sulpiride].
Joshita Y
Nihon Naika Gakkai Zasshi; 1987 Jan; 76(1):59-66. PubMed ID: 3106541
[No Abstract] [Full Text] [Related]
31. Positron emission tomography in minor ischemic stroke using oxygen-15 steady-state technique.
Pozzilli C; Itoh M; Matsuzawa T; Fukuda H; Abe Y; Sato T; Takeda S; Ido T
J Cereb Blood Flow Metab; 1987 Apr; 7(2):137-42. PubMed ID: 3494026
[TBL] [Abstract][Full Text] [Related]
32. Influence of intravenously administered catecholamines on cerebral oxygen consumption and blood flow in the rat.
Berntman L; Dahlgren N; Siesjö BK
Acta Physiol Scand; 1978 Sep; 104(1):101-8. PubMed ID: 696350
[TBL] [Abstract][Full Text] [Related]
33. [Patients with stroke treated with TRH-T. Evaluation of electric brain activity using traditional and computerized methods].
Bramanti P; Di Bella P; Ricci RM; De Luca GP; De Bartolo M; Di Perri R
Clin Ter; 1990 Apr; 133(1):19-23. PubMed ID: 2140740
[TBL] [Abstract][Full Text] [Related]
34. [The effect of the thyrotropin releasing hormone (TRH) on the motor speech disorder in spinocerebellar degeneration].
Nozaki Y; Hashimoto M; Ohnishi A; Murai Y; Ogata H; Makishima K
J UOEH; 1992 Jun; 14(2):173-83. PubMed ID: 1621012
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of thyrotropin releasing hormone (TRH) on motor execution and motor adaptation process in patients with spinocerebellar degeneration.
Shimizu T; Tsutsumi R; Shimizu K; Tominaga N; Nagai M; Ugawa Y; Nishiyama K; Hanajima R
J Neurol Sci; 2020 Aug; 415():116927. PubMed ID: 32474221
[TBL] [Abstract][Full Text] [Related]
36. Positron emission tomography in patients with a primary intracerebral hematoma.
Uemura K; Shishido F; Higano S; Inugami A; Kanno I; Takahashi K; Yasui N; Tagawa K
Acta Radiol Suppl; 1986; 369():426-8. PubMed ID: 2980516
[TBL] [Abstract][Full Text] [Related]
37. [The effect of glycerol on regional cerebral blood flow, blood volume and oxygen metabolism].
Ishikawa M; Kikuchi H; Nagata I; Yamagata S; Taki W; Kobayashi A; Yonekura Y; Nishizawa S
No Shinkei Geka; 1989 Jul; 17(7):635-40. PubMed ID: 2812264
[TBL] [Abstract][Full Text] [Related]
38. Measurement of cerebral blood flow (CBF) with the Kety and Schmidt technique during craniotomy.
Cold GE; Madsen JB; Knudsen L
Agressologie; 1991; 32(6-7):345-51. PubMed ID: 1843839
[TBL] [Abstract][Full Text] [Related]
39. Thyrotropin-releasing hormone (TRH) causes sympathetic activation and cerebral vasodilation in the rabbit.
Koskinen LO; Bill A
Acta Physiol Scand; 1984 Oct; 122(2):127-36. PubMed ID: 6097095
[TBL] [Abstract][Full Text] [Related]
40. [Regional hemodynamic and metabolic consequences of temporo-sylvian anastomosis. Study of 15 patients by positron emission tomography].
Samson Y; Baron JC; Bousser MG; Rey A; Roux FX; Derlon JM; Comoy J; David P; Comar D
Neurochirurgie; 1985; 31(1):31-6. PubMed ID: 3873625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
